The role of in vitro alloreactive T-cell functional tests in the selection of HLA matched and mismatched haematopoietic stem cell donors

Transplant Immunology

Volumn 10, Issue 2-3, 2002, Pages 205-214

  Jeras, Matjaž ^a  

^a BLOOD TRANSFUSION CENTRE OF SLOVENIA   (Slovenia)

Author keywords

Alloreactivity; Haematopoietic stem cell transplantation (HSCT); Histocompatibility; T lymphocyte functional tests

Indexed keywords

DNA; HLA ANTIGEN; HLA ANTIGEN CLASS 1; HLA ANTIGEN CLASS 2; MINOR HISTOCOMPATIBILITY ANTIGEN;

ALLOIMMUNITY; ASSAY; BLOOD GROUP INCOMPATIBILITY; CYTOTOXIC T LYMPHOCYTE; DNA TRANSCRIPTION; GENETIC ANALYSIS; GRAFT REJECTION; GRAFT VERSUS HOST REACTION; HELPER CELL; HEMATOPOIETIC STEM CELL TRANSPLANTATION; HISTOCOMPATIBILITY COMPLEX; HLA MATCHING; HUMAN; IMMUNOCOMPETENT CELL; IMMUNOGENICITY; IN VITRO STUDY; MIXED LYMPHOCYTE REACTION; ORGAN DONOR; POLYMERASE CHAIN REACTION; PRIORITY JOURNAL; PROTEIN POLYMORPHISM; QUANTITATIVE ANALYSIS; RECIPIENT; REVIEW; SEROLOGY; SIBLING; T LYMPHOCYTE ACTIVATION; T LYMPHOCYTE SUBPOPULATION; TREATMENT OUTCOME;

ANTIGEN PRESENTATION; CYTOTOXICITY TESTS, IMMUNOLOGIC; DNA REPLICATION; ENZYME-LINKED IMMUNOSORBENT ASSAY; GRAFT REJECTION; GRAFT VS HOST DISEASE; HEMATOPOIETIC STEM CELL TRANSPLANTATION; HISTOCOMPATIBILITY TESTING; HLA ANTIGENS; HUMANS; LYMPHOCYTE COUNT; LYMPHOCYTE CULTURE TEST, MIXED; PEPTIDE FRAGMENTS; POLYMORPHISM, GENETIC; RECEPTORS, ANTIGEN, T-CELL; T-LYMPHOCYTES, CYTOTOXIC; T-LYMPHOCYTES, HELPER-INDUCER; TISSUE DONORS; TRANSPLANTATION, HOMOLOGOUS;

EID: 0036344929     PISSN: 09663274     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0966-3274(02)00067-9     Document Type: Review

References (69)

1. Bone Marrow Donors Worldwide: A successful exercise in international cooperation
2. HLA-DRB1 DNA sequencing based typing: An approach suitable for high throughput typing including unrelated bone marrow registry donors
3. Validation of DNA-based HLA-A and HLA-B testing of volunteers for a bone marrow registry through parallel testing with serology
4. Lymphocyte interaction: A potential histocompatibility test in vitro
5. The development of large immature mononuclear cells in mixed lymphocyte cultures
6. Evaluation of the mixed lymphocyte culture (MLC) assay as a method for selecting unrelated donors for marrow transplantation
7. Bone marrow transplantation with unrelated donors: HLA class II olegonucleotide typing as predictive of mixed lymphocyte culture reactivity
8. Unrelated donor matching for bone marrow transplantation
9. HLA-DRβIII and HLA-DP induce comparable proliferation in primary mixed lymphocyte culture
10. HLA-DP and allogeneic bone marrow transplantation
11. HLA-DP incompatibilities induce significant proliferation in primary mixed lymphocyte cultures in HLA-A, -B, -DR and -DQ compatible individuals: Implications for allogeneic bone marrow transplantation
12. Do functional assays have predictive value in sibling bone marrow transplantation?
13. Early detection of the allogeneic effect in the mixed lymphocyte reaction (MLR) by ant-CD3 IgA mouse monoclonal antibody
14. Interleukin 12 unmasks HLA class I differences during mixed lymphocyte reaction induced interferon gamma production
15. Interferon-γ-based mixed lymphocyte culture as a selection tool for allogeneic bone marrow donors other than identical siblings
16. Limiting dilution analysis of cells of the immune system II: What can be learnt?
17. Limiting dilution analysis of human T cells: A useful clinical tool
18. The evaluation of limiting dilution assays
19. Limiting dilution assays for the determination of immunocompetent cell frequencies. III. Validity tests for the single-hit Poisson model
20. Limiting dilution assays. Experimental design and statistical analysis
21. Estimation by limiting dilution analysis of human IL 2-secreting T cells: Detection of IL 2 produced by single lymphokine-secreting T cells
22. Frequency of human alloantigen-reactive T lymphocytes. II. Method for limiting dilution analysis of alloantigen-reactive helper T cells in human peripheral blood
23. The relative radioresistance of interleukin-2 production by human peripheral blood lymphocytes: Consequences for the development of a new limiting dilution assay for the enumeration of helper T lymphocyte precursor frequencies
24. Enumeration of human alloreactive helper T lymphocyte precursor frequencies by limiting dilution analysis of interleukin-2 production
25. Optimizing a limiting dilution culture system for quantifying the frequency of interleukin-2-producing alloreactive T helper lymphocytes
26. T-lymphocyte-antigen interactions in transplant rejection
27. Optimal analysis of composite cytokine responses during alloreactivity
28. Long term culture of tumour-specific cytotoxic T cells
29. A T cell clone which responds to interleukin 2 but not to interleukin 4
30. Limiting dilution analysis of human IL-2 producing T-cell precursors. Determination of hierarchical alloantigenic potential of human leukocyte antigens and evaluation of alloimmune responses to single HLA-DP molecules
31. HLA-DRB1 amino acid disparity is the major stimulus of interleukin-2 production by alloreactive helper T-lymphocytes
32. Helper T-lymphocyte precursor frequencies predict risks of graft-versus-host disease in bone marrow transplantation
33. Comparison of helper and cytotoxic antirecipient T cell frequencies in unrelated bone-marrow transplantation
34. Presence of host-specific interleukin 2-secreting T helper cell precursors correlates closely with active primary and secondary chronic graft-versus-host disease
35. Donor helper T-cell frequencies as predictors of acute graft-versus-host disease in bone marrow transplantation between HLA-identical siblings
36. Predictive value of host-specific donor helper T-cell precursor frequency for acute graft-versus-host disease and relapse in HLA-identical siblings receiving allogeneic bone marrow transplantation for hematological malignancies
37. Frequency of anti-recipient alloreactive helper T-cell precursors in donor blood and graft-versus-host disease after HLA-identical sibling bone-marrow transplantation
38. Positive correlation of T cell sensitization with frequencies of alloreactive T helper cells in chronic renal failure patients
39. Could analysis of helper T-cell precursor frequencies be used as a predictive parameter in renal transplantation?
40. Immunological monitoring in peripheral blood after heart transplantation: Frequencies of T-helper cells and precursors of cytotoxic T cells with high avidity for donor antigens correlate with rejection
41. Quantitative assay of the lytic action of immune lymphoid cells on 51-Cr-labelled allogeneic target cells in vitro; Inhibition by isoantibody and by drugs
42. Measuring human T-lymphocyte function
43. Cell mediated lympholysis in man after sensitization of effector lymphocytes through mixed leukocyte cultures
44. Quantitative assessment of the pool size and subsets distribution of cytolitic T lymphocytes within human resting or alloactivated peripheral blood T cell populations
45. Human cytotoxic T lymphocytes. I. Limiting-dilution analysis of alloreactive cytotoxic T-lymphocyte precursor frequencies
46. The effect of individual HLA-A and -B mismatches on the generation of cytotoxic T lymphocyte precursors
47. Variations in the T-cell repertoire against HLA antigens in humans
48. Optimising a limiting dilution culture system for quantitating frequencies of alloreactive cytotoxic T lymphocyte precursors
49. Determination of cytotoxic T lymphocyte precursor frequencies using europium labeling as a nonradioactive alternative to labeling with chromium-51
50. Prediction of graft versus host disease by frequency analysis of cytotoxic T cells after unrelated donor bone marrow transplantation
51. Cytotoxic T lymphocyte precursor (CTL-p) frequency analysis in unrelated donor bone marrow transplantation: Two case studies
52. The frequency of pretransplant donor cytotoxic T cell precursors with anti-host specificity predicts survival of patients transplanted with bone marrow from donors other than HLA-identical siblings
53. Cytotoxic T lymphocyte precursor frequency analyses in bone marrow transplantation with volunteer unrelated donors. Value in donor selection
54. High resolution HLA matching with decreased mortality after unrelated bone marrow transplantation
55. Pretransplant cytotoxic T-cell activity specific to patient HLA class I antigens correlating with mortality after unrelated BMT
56. Measurement of cytotoxic T lymphocyte precursor frequencies reveals cryptic HLA class I mismatches in the context of unrelated donor bone marrow transplantation
57. Cytotoxic T-lymphocyte precursor frequency (CLp-f) as a tool for distinguishing permissible from non-permissible class I mismatches in T-cell-depleted allogeneic bone marrow transplantation
58. Analysis of the donor-specific cytotoxic T-cell repertoire in a patient with a long-term surviving kidney allograft
59. IgG antibodies against an HLA antigen are associated with activated cytotoxic T cells against this antigen, IgM are not
60. The presence of activated donor HLA class I-reactive T lymphocytes is associated with rejection of corneal grafts
61. Progressive accumulation of CTL with high avidity for donor antigens during the development of acute cardiac rejection
62. + T lymphocytes producing tumor necrosis factor alpha spots in response to peptide antigens
63. T helper type-1 (Th1)/Th2 profiles of peripheral blood mononuclear cells (PBMC); Responses to antigens of Chlamydia trachomatis in subjects with severe trachomatous scarring
64. + T cells using an ELISPOT assay
65. Competition of peptide-MHC class I tetrameric complexes with anti-CD3 provides evidence for specificity of peptide binding to the TCR complex
66. + T cells in melanoma patients
67. + T cells in HIV-infected children, using major histocompatibility complex class I peptide tetramers
68. Activated human epitope-specific T cells identified by class II tetramers reside within a CD4 high, proliferating subset